Most Popular in:
New in Regulations (page 10 of 15)
The Psoriasis and Psoriatic Arthritis Research Cure and Care Act (PPARCCA) of 2009 (H.R. 930) has been reintroduced in the U.S. House of Representatives.
By: Imogen Matthews
Product claims sell skin care, yet increasingly savvy consumers are questioning whether these claims really stand up to scrutiny. What are the challenges facing beauty brands in making claims in various markets?
By: Carl Thornfeldt, MD
Knowing the difference between natural and organic can help you determine what's best for your clients.
Ignited by global growth in the use of topical anesthetics for cosmetic procedures, the U.S. Food and Drug Administration (FDA) has issued a health warning after a study concluded that the drug lidocaine carries risks.
The Personal Care Products Council has announced the appointment of two new members to the Cosmetic Ingredients Review (CIR) Expert Panel.
The year has seen the strengthening of all things green in both the political and public consciousness. However, how is the cosmetics industry reacting to these shifting ideals and principles?
A panel organized by the Citizens for Sun Protection recently convened to put pressure on the FDA to adopt new sunscreen standards.
PBA's director of government affairs outlines upcoming congressional issues that will affect the spa industry.
Consumers may not be fully informed of the potential dangers of wrinkle injections, according to an FDA panel.
The U.S. Food and Drug Administration (FDA) has published fresh warning letters to tackle the problem of companies that incorrectly market their products as cosmetics.